Skip to main content
Log in

Oxygen radical formation and DNA damage due to enzymatic reduction of bleomycin-Fe(III)

  • Original Investigations
  • Radical Mechanisms and Lipid Peroxidation
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Aerobic incubations of bleomycin, FeCl3, DNA, NADPH, and isolated liver microsomal NADPH-cytochrome P-450 reductase resulted in NADPH and oxygen consumption and malondialdehyde formation, indicating that the deoxyribose moiety of DNA was split. All parameters measured depended on the active enzyme, bleomycin and FeCl3. In the absence of oxygen malondialdehyde formation was very low.

When bleomycin, FeCl3 and the reductase were incubated with methional ethene (ethylene) was formed, suggesting that during the enzyme-catalyzed redox cycle of bleomycin-Fe(III/II) hydroxyl radicals were formed. Ethene formation also depended on oxygen, NADPH, the enzyme, bleomycin, and FeCl3.

During aerobic incubations of bleomycin, FeCl3, NADPH, and isolated liver nuclei oxygen and NADPH were consumed and malondialdehyde was formed. Oxygen and NADPH consumption and malondialdehyde formation depended on bleomycin and FeCl3. In the absence of oxygen malondialdehyde was not formed. These results indicate that nuclear NADPH-cytochrome P-450 reductase redox cycles the bleomycin-Fe(III/II) complex and that the reduced complex activates oxygen, whereby hydroxyl radicals are formed which damage the deoxyribose of nuclear DNA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Berend N (1984) Protective effect of hypoxia on bleomycin lung toxicity in the rat. Am Rev Respir Dis 130: 307–308

    Google Scholar 

  • Bishun NP, Smith NS, Williams DC (1978) Bleomycin (review). Oncology 35: 228–234

    Google Scholar 

  • Burger RM, Peisach J, Horwitz SB (1981) Mechanism of bleomycin action: In vitro studies (minireview). Life Sci 28: 715–727

    Google Scholar 

  • Carter SK, Crooke ST, Umezawa H (1978) Bleomycin, current status and new developments. Academic Press, New York

    Google Scholar 

  • Chandler DB, Fulmer JD (1985) The effect of deferoxamine on bleomycin-induced lung fibrosis in the hamster. Am Rev Respir Dis 131: 596–598

    Google Scholar 

  • Cunningham ML, Ringrose PS, Lokesh BR (1983) Bleomycin cytotoxicity is prevented by superoxide dismutase in vitro. Cancer Lett 21: 149–153

    Google Scholar 

  • Cunningham ML, Ringrose PS, Lokesh BR (1984) Inhibition of the genotoxicity of bleomycin by superoxide dismutase. Mutat Res 135: 199–202

    Google Scholar 

  • Gebbers JO, Burkhardt A (1982) Pulmonary lesions induced by bleomycin. In: Zbinden G (ed) Lectures in toxicology. Pergamon Press, Oxford, pp 1–6

    Google Scholar 

  • Giloni L, Takeshita M, Johnson F, Iden C, Grollman AP (1981) Bleomycin-induced strand-scission of DNA — mechanism of deoxyribose cleavage. J Biol Chem 256: 8608–8615

    Google Scholar 

  • Grollman AP, Takeshita M, Pillai KMR, Johnson F (1985) Origin and cytotoxic properties of base propenals derived from DNA. Cancer Res 45: 1127–1131

    Google Scholar 

  • Gutteridge JMC, Rowley DA, Halliwell B (1981) Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Biochem J 199: 263–265

    Google Scholar 

  • Kappus H, Mahmutoglu I (1986) Oxygen radical formation during redox cycling of bleomycin-Fe(III) catalyzed by NADPH-cytochrome P-450 reductase of liver microsomes and nuclei. In: Kocsis JJ, Jollow DJ, Witmer ChM, Nelson JO, Snyder R (eds) Biological reactive intermediates III — Mechanisms of action in animal models and human disease, Plenum Press, New York, pp 273–280

    Google Scholar 

  • Kappus H, Kieczka H, Scheulen M, Remmer H (1977) Molecular aspects of catechol and pyrogallol inhibition of liver micro-somal lipid peroxidation stimulated by ferrous ion-ADP-complexes or by carbon tetrachloride. Naunyn-Schmiedeberg's Arch Pharmacol 300: 179–187

    Google Scholar 

  • Kappus H, Muliawan H and Scheulen ME (1982) Liver microsomal lipid peroxidation by bleomycin-ferrous-oxygen-complexes. In: Sato R, Kato R (eds) Microsomes, drug oxidations, and drug toxicity. Japan Scientific Societies Press, Tokyo New York, pp 555–556

    Google Scholar 

  • Kilkuskie RE, Macdonald TL, Hecht SM (1984) Bleomycin may be activated for DNA cleavage by NADPH-cytochrome P-450 reductase. Biochemistry 23: 6165–6171

    Google Scholar 

  • Mahmutoglu I, Kappus H (1985) Oxy radical formation during redox cycling of the bleomycin-iron(III) complex by NADPH-cytochrome P-450 reductase. Biochem Pharmacol 34: 3091–3094

    Google Scholar 

  • Pepin JM, Langner RO (1985) Effects of dimethyl sulfoxide (DMSO) on bleomycin-induced pulmonary fibrosis. Biochem Pharmacol 34: 2386–2388

    Google Scholar 

  • Povirk LF (1983) Bleomycin. In: Neidle S, Waring MJ (eds) Molecular aspects of anti-cancer drug action. Topics in molecular and structural biology, vol 3. Macmillan Press, London, pp 157–181

    Google Scholar 

  • Romano M, Clos V, Assael BM, Salmona M (1982) Perinatal development of cytochrome P-450, NADPH-cytochrome c reductase and ethoxycoumarin deethylase in rat liver nuclear membranes. Chem Biol Interact 42: 225–231

    Google Scholar 

  • Romano M, Facchinetti T, Salmona M (1983) Is there a role for nuclei in the metabolism of xenobiotica — a review. Drug Metab Rev 14: 803–829

    Google Scholar 

  • Sagara Y, Harano T, Omura T (1978) Characterization of electron transport enzymes in the envelope of rat liver nuclei. J Biochem (Tokyo) 83: 807–812

    Google Scholar 

  • Sausville EA, Peisach J, Horwitz SB (1978) Effect of chelating agents and metal ions on the degradation of DNA by bleomycin. Biochemistry 17: 2740–2746

    Google Scholar 

  • Scheulen ME, Kappus H, Thyssen D, Schmidt CG (1981) Redox cycling of Fe(III)-bleomycin by NADPH-cytochrome P-450 reductase. Biochem Pharmacol 30: 3385–3388

    Google Scholar 

  • Scheulen ME, Kappus H (1984) The activation of oxygen by bleomycin is catalyzed by NADPH-cytochrome P-450 reductase in the presence of iron ions and NADPH. In: Bors W, Saran M, Tait D (eds) Oxygen radicals in chemistry and biology, de Gruyter, Berlin New York, pp 425–433

    Google Scholar 

  • Trush MA, Mimnaugh EG, Ginsburg E, Gram TE (1982) Studies on the interaction of Bleomycin A2 with rat lung microsomes. I. Characterization of factors which influence bleomycin-mediated DNA chain breakage. J Pharmacol Exp Ther 221: 152–158

    Google Scholar 

  • Wu JC, Kozarich JW, Stubbe JA (1983) The mechanism of free base formation from DNA by bleomycin. J Biol Chem 258: 4694–4697

    Google Scholar 

  • Yamanaka N, Kato T, Nishida K, Ota K (1978) Enhancement of DNA chain breakage by bleomycin A2 in the presence of microsomes and reduced nicotinamide adenine dinucleotide phosphate. Cancer Res 38: 3900–3903

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Professor Dr. med. Herbert Remmer on the occasion of his 65th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mahmutoglu, I., Scheulen, M.E. & Kappus, H. Oxygen radical formation and DNA damage due to enzymatic reduction of bleomycin-Fe(III). Arch Toxicol 60, 150–153 (1987). https://doi.org/10.1007/BF00296969

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296969

Key words

Navigation